2024-10-01 - Analysis Report
## Thermo Fisher Scientific Inc (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc is a leading provider of scientific instruments, reagents, and consumables for research, diagnostics, and pharmaceutical manufacturing.

**1. Performance and Relative Strength:**

* **Cumulative Return:** TMO has delivered a cumulative return of 254.4%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 133.28%.
* **Outperformance vs. S&P 500:**  TMO currently exhibits an outperformance of 121.12% against the S&P 500,  representing a relative strength ranking of 55.8% (based on historical data). 

**2. Recent Price Movement:**

* **Closing Price:** 618.22
* **5-day Moving Average:** 611.62
* **20-day Moving Average:** 613.32
* **60-day Moving Average:** 594.29

TMO's recent price action indicates a slight upward trend, with the current price trading above its 5-day, 20-day, and 60-day moving averages.

**3. Technical Indicators:**

* **RSI:** 48.51 (Neutral): The RSI is hovering near the middle of the range, suggesting neither overbought nor oversold conditions.
* **PPO:** -0.13 (Slightly Bearish): The PPO is slightly negative, indicating a potential for short-term weakness.
* **Delta_Previous_Relative_Divergence:** -1.03 (Short-Term Downward Trend): The negative divergence suggests a recent decline in relative strength compared to previous periods. 
* **Expected Return:** 10.03% (Potential 5-year expected return): The expected return represents the estimated potential return for the next 5 years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue | 
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

The most recent earnings results (2024-08-02)  showed a beat against analyst expectations, indicating positive momentum in the company's performance. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** Several analysts maintain a bullish stance on TMO, highlighting its strong market position, consistent growth, and potential for continued expansion in the scientific instruments and diagnostics markets.
* **Analyst Opinions:**  Finbold reports a consensus "Buy" rating with an average price target of $640.85.
* **Performance Highlights:** TMO's focus on research and development, innovative products, and global reach has been instrumental in its successful track record. 

**6. Overall Analysis:**

TMO's strong historical performance, recent earnings beat, and positive market outlook suggest continued growth potential. The stock is currently trading at a slightly elevated level relative to the broader market, but its strong fundamentals and potential for continued market share gains warrant consideration. 

**7.  Key Considerations:**

* TMO's valuation relative to its peers should be carefully assessed.
*  Global economic conditions and potential regulatory changes could impact the company's growth trajectory.
* Investors should monitor the company's future earnings releases and announcements for further insights into its performance.

**Disclaimer:** This report is for informational purposes only and should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.